July 1st 2024
Pyzchiva will be commercialized by Sandoz in the United States.
"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation
View More
PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa
View More
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Study Results for Patients With Generalized Pustular Psoriasis
Aaron S. Farberg, MD, and Jeffrey Crowley, MD, examine the results of a study of generalized pustular psoriasis, discussing flares and common signs and symptoms.
Baseline Characteristics of Patients With Generalized Pustular Psoriasis
Aaron S. Farberg, MD, and Jeffrey Crowley, MD, review the demographics of people with generalized pustular psoriasis including age, race, and comorbidities.
Understanding Flares in Patients With GPP Documented in US Electronic Health Records
Expert dermatologists discuss the methods of a study of US health records of patients with generalized pustular psoriasis.
Overview of Generalized Pustular Psoriasis (GPP)
Aaron S. Farberg, MD, and Jeffrey Crowley, MD, provide an overview of generalized pustular psoriasis, identifying flares, the burden on patients, and available treatment options.